Know Cancer

or
forgot password

Predictive Value of FDG-TEP During Exclusive Chemo-Radiotherapy (CRT) in Patients With Oesophageal Carcinoma Cancer on the One-Year Survival (RTEP3)


N/A
18 Years
N/A
Open (Enrolling)
Both
Oesophageal Cancer

Thank you

Trial Information

Predictive Value of FDG-TEP During Exclusive Chemo-Radiotherapy (CRT) in Patients With Oesophageal Carcinoma Cancer on the One-Year Survival (RTEP3)


Inclusion Criteria:



- Carcinoma ├ępidermo├»de of the oesophagus histologically proved, UICC Stage II B, III
or IVa (TNM on 2002)

- Decision of treatment by radio concomitant chemotherapy (radiotherapy in classic
spreading of 50Gy associated with a platinum chemotherapy.

Exclusion Criteria:

- Presence of a second evolutionary cancer in the previous three years

- index of performance OMS > 2

- Patients badly balanced diabetics

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

VERA Pierre, MD phD

Investigator Role:

Principal Investigator

Investigator Affiliation:

CHBecquerel

Authority:

France: Institutional Ethical Committee

Study ID:

CHB08-02

NCT ID:

NCT00934505

Start Date:

May 2009

Completion Date:

April 2014

Related Keywords:

  • Oesophageal Cancer
  • Positron-Emission Tomography
  • PET Scan
  • FDG
  • oesophageal cancer
  • chemo-Radiation Oncology
  • SUV
  • Carcinoma
  • Esophageal Diseases
  • Esophageal Neoplasms

Name

Location